Influence of a supplementation with vitamins on cardiovascular morbidity and mortality in patients with end-stage renal disease: design and baseline data of a randomized clinical trial

被引：0
|
作者：
Heinz, J. [1 ]
Domroese, U. [2 ]
Luley, C. [2 ]
Westphal, S. [3 ]
Kropf, S. [3 ]
Neumann, K. H. [2 ]
Dierkes, J. [3 ]
机构：
[1] Univ Hosp Magdeburg, Inst Clin Chem, D-39120 Magdeburg, Germany
[2] Univ Hosp Magdeburg, Div Nephrol, D-39120 Magdeburg, Germany
[3] Univ Hosp Magdeburg, Inst Biometry & Med Informat, D-39120 Magdeburg, Germany
来源：
CLINICAL NEPHROLOGY | 2009年 / 71卷 / 03期
关键词：
VASCULAR-DISEASE; FOLIC-ACID; HYPERHOMOCYSTEINEMIA; PREVENTION;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：363 / 365
页数：3
相关论文
共 50 条
  • [41] Bone mineral density in end-stage renal disease patients:: Association with wasting, cardiovascular disease and mortality
    Matsubara, Keisuke
    Suliman, Mohamed E.
    Qureshi, Abdul Rashid
    Axelsson, Jonas
    Martola, Leena
    Heimbuerger, Olof
    Barany, Peter
    Stenvinkel, Peter
    Lindholm, Bengt
    BLOOD PURIFICATION, 2008, 26 (03) : 284 - 290
  • [42] Vitamins E & C in patients with end-stage renal disease undergoing hemodialysis
    Smith, KS
    Ridlington, JW
    Leonard, SW
    Mitchel, N
    Traber, MG
    FASEB JOURNAL, 2002, 16 (05): : A989 - A989
  • [43] Cardiovascular risk factors in hemodialysis patients: Results from baseline data of kaleidoscopic approaches to patients with end-stage renal disease study
    Ohsawa, M
    Kato, K
    Itai, K
    Onoda, T
    Konda, R
    Fujioka, T
    Nakamura, M
    Okayama, A
    JOURNAL OF EPIDEMIOLOGY, 2005, 15 (03) : 96 - 105
  • [44] CLINICAL PREDICTORS OF CORONARY ARTERY CALCIFICATION IN END-STAGE RENAL DISEASE PATIENTS: THE PACE (PREDICTORS OF ARRHYTHMIC AND CARDIOVASCULAR RISK IN END-STAGE RENAL DISEASE) STUDY
    Magalhaes, Tiago A.
    Rizzi, Patricia B.
    Meoni, Lucy
    Jaar, Bernard
    Sozio, Steve
    Estrella, Michelle
    Kao, Wen-Hong
    Santaularia-Tomas, Miguel
    Lima, Joao A.
    Parekh, Rulan S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1151 - E1151
  • [45] Outcomes of end-stage renal disease patients in the PROCESS trial
    Huebinger, Ryan M.
    Walia, Shabana
    Yealy, Donald M.
    Kellum, John A.
    Huang, David T.
    Wang, Henry E.
    JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN, 2021, 2 (01)
  • [46] Chlamydia pneumoniae, overall and cardiovascular mortality in end-stage renal disease (ESRD)
    Zoccali, C
    Mallamaci, F
    Tripepi, G
    Parlongo, S
    Cutrupi, S
    Benedetto, FA
    Bonanno, G
    Seminara, G
    Fatuzzo, P
    Rapisarda, F
    Malatino, LS
    KIDNEY INTERNATIONAL, 2003, 64 (02) : 579 - 584
  • [47] CIRCULATING ENDOTHELIAL MICROPARTICLES PREDICT CARDIOVASCULAR MORTALITY IN END-STAGE RENAL DISEASE
    Pannier, B.
    Guerin, A.
    Amabile, N.
    Boulanger, C.
    Tedgui, A.
    London, G.
    JOURNAL OF HYPERTENSION, 2010, 28 : E30 - E30
  • [48] Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease
    Shoji, T
    Emoto, M
    Shinohara, K
    Kakiya, R
    Tsujimoto, K
    Kishimoto, H
    Ishimura, E
    Tabata, T
    Nishizawa, Y
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2001, 12 (10): : 2117 - 2124
  • [49] High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patients
    Molnar, Miklos Z.
    Streja, Elani
    Kovesdy, Csaba P.
    Budoff, Matthew J.
    Nissenson, Allen R.
    Krishnan, Mahesh
    Anker, Stefan D.
    Norris, Keith C.
    Fonarow, Gregg C.
    Kalantar-Zadeh, Kamyar
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2011, 94 (03): : 945 - 954
  • [50] The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure - A randomized, controlled trial
    Tepel, M
    van der Giet, M
    Statz, M
    Jankowski, J
    Zidek, W
    CIRCULATION, 2003, 107 (07) : 992 - 995
12345